ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: GFAP
Storage: 2-8C
Application: Immunofluorescence Analysis: A 1:100 dilution from a representative lot detected GFAP in human brain and rat brain tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected GFAP in C6 glioblastoma cells and primary cultures of rat glial precursor cells.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected GFAP in rat brain and human brain tissue sections.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany